clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01047566 |
P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
P17 | country | Netherlands | Q55 |
P582 | end time | 2011-09-01 | |
P1050 | medical condition | Atrial Fibrillation | Q815819 |
P2899 | minimum age | 46 | |
P1132 | number of participants | 183 | |
P4844 | research intervention | dronedarone | Q408637 |
calcium oxalate | Q412399 | ||
digoxin | Q422222 | ||
P6153 | research site | Sanofi | Q158205 |
P1813 | short name | AFRODITE | |
P580 | start time | 2010-04-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | The Effect of the Addition of Dronedarone to, Versus Increase of, Existing Conventional Rate Control Medication on Ventricular Rate During Persistent Atrial Fibrillation |
Search more.